Treatment with SP600125, the inhibitor of JNK, time-dependently suppressed migration of PANC-1 cells, suggesting the basal activity of the JNK pathway promoted migration of pancreatic cancer cells. The gene discussed is MAPK8; the disease is familial pancreatic carcinoma.